Dementia Research Oxford
Our vision is to transform research and healthcare in dementia. Dementia Research Oxford, led by Professors Masud Husain and Cornelia van Duijn, brings together researchers and clinicians across the University, our hospitals, patients, and industry partners to translate our growing insights in the basic molecular origin disease into effective treatment and prevention. We aim to take science further from drug target to treatment, from molecular pathology to early diagnosis and prognosis and from early intervention to prevention.
From drug target to treatment
Combining our powerful chemistry with PET imaging provides the potential to monitor how drugs interact with their targets in the brain to improve development of new therapies.
From molecular pathology to early diagnosis and prognosis
Using state of the art molecular research and big data analysis allows us to improve early diagnosis and monitor disease process long before the onset of dementia.
FROM EARLY INTERVENTION TO PREVENTION
Based our renowned clinical trial centre and world class clinical and preventive trial expertise, our ambition is to move new potential drugs and life style interventions to the clinic and curb the epidemic of dementia.